Announced
Financials
Sources
Tags
Majority
Pending
Single Bidder
medtech
Cross Border
Private
Acquisition
Friendly
United States
Medical Services
Synopsis
Senzime, a medical device company, agreed to acquire Respiratory Motion, a medtech company, for $44m. ”This is an acquisition with perfect logic. Respiratory Motion gives us the conditions to further accelerate the rollout of TetraGraph while expanding our business of monitoring patients' respiratory function outside the operating room. With Respiratory Motion's unique system, we reach three times as large patient volume and lay the next building block in our journey to be the market leader in precision-based monitoring of vital signs with the overarching mission of eliminating anesthesia and sedation-related complications.” Pia Renaudin, Senzime CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.